Skip to main content
Erschienen in: World Journal of Surgery 3/2005

01.03.2005 | Surgical Oncology

Prognosis of Hepatocellular Carcinoma after Hepatectomy in Patients with Renal Dysfunction

verfasst von: Masaki Kaibori, M.D., Yoichi Matsui, M.D., A-Hon Kwon, M.D., Toshiko Tokoro, M.D., Yasuo Kamiyama, M.D.

Erschienen in: World Journal of Surgery | Ausgabe 3/2005

Einloggen, um Zugang zu erhalten

Abstract

We evaluated the effect of renal dysfunction on the prognosis of hepatocellular carcinoma in 224 patients who underwent hepatic resection. Survival was compared between patients with (57 patients) and without renal dysfunction (116 patients), using a creatinine clearance ≤70 ml/min as the cut-off value. There were no significant differences with respect to other preoperative characteristics, operative findings, or histology between the two groups. There was also no difference in survival between the two groups after hepatic resection. However, among 132 patients with a solitary tumor measuring ≤5 cm in greatest dimension, the disease-free and overall survival rates of 36 patients with renal dysfunction were significantly worse after resection than those of the patients without renal dysfunction (p = 0.04 and p = 0.0003, respectively). By multivariate analysis, renal dysfunction was an independent factor indicating a poor prognosis for disease-free and overall survival after resection of small solitary tumors (p = 0.0401 and p = 0.0031, respectively). Renal dysfunction did not affect the overall prognosis after resection of hepatocellular carcinoma, but it worsened the prognosis of patients with small solitary lesions.
Literatur
1.
Zurück zum Zitat Fan, ST, Lo, CM, Liu, CL, et al. 1999Hepatectomy for hepatocellular carcinoma: toward zero hospital deaths, AnnSurg.229322330 Fan, ST, Lo, CM, Liu, CL,  et al. 1999Hepatectomy for hepatocellular carcinoma: toward zero hospital deaths, AnnSurg.229322330
2.
Zurück zum Zitat Tung-Ping Poon, R, Fan, ST, Wong, J 2000Risk factors, prevention, and management of postoperative recurrence after resection of hepatocellular carcinomaAnn. Surg.2321024CrossRefPubMed Tung-Ping Poon, R, Fan, ST, Wong, J 2000Risk factors, prevention, and management of postoperative recurrence after resection of hepatocellular carcinomaAnn. Surg.2321024CrossRefPubMed
3.
Zurück zum Zitat Shimada, M, Takenaka, K, Fujiwara, Y, et al. 1996Des-gamma-carboxy prothrombin and alpha-fetoprotein positive status as a new prognostic indicator after hepatic resection for hepatocellular carcinomaCancer7820942100CrossRefPubMed Shimada, M, Takenaka, K, Fujiwara, Y,  et al. 1996Des-gamma-carboxy prothrombin and alpha-fetoprotein positive status as a new prognostic indicator after hepatic resection for hepatocellular carcinomaCancer7820942100CrossRefPubMed
4.
Zurück zum Zitat Takenaka, K, Kawahara, N, Yamamoto, K, et al. 1996Results of 280 liver resections for hepatocellular carcinomaArch. Surg.1317176PubMed Takenaka, K, Kawahara, N, Yamamoto, K,  et al. 1996Results of 280 liver resections for hepatocellular carcinomaArch. Surg.1317176PubMed
5.
Zurück zum Zitat Arii, S, Tanaka, J, Yamazoe, Y, et al. 1992Predictive factors for intrahepatic recurrence of hepatocellular carcinoma after partial hepatectomyCancer69913919PubMed Arii, S, Tanaka, J, Yamazoe, Y,  et al. 1992Predictive factors for intrahepatic recurrence of hepatocellular carcinoma after partial hepatectomyCancer69913919PubMed
6.
Zurück zum Zitat Jwo, SC, Chiu, JH, Chau, GY, et al. 1992Risk factors linked to tumor recurrence of human hepatocellular carcinoma after hepatic resectionHepatology1613671371PubMed Jwo, SC, Chiu, JH, Chau, GY,  et al. 1992Risk factors linked to tumor recurrence of human hepatocellular carcinoma after hepatic resectionHepatology1613671371PubMed
7.
Zurück zum Zitat Otto, G, Heuschen, U, Hofmann, WJ, et al. 1998Survival and recurrence after liver transplantation versus resection for hepatocellular carcinoma: a retrospective analysisAnn. Surg.227424432CrossRefPubMed Otto, G, Heuschen, U, Hofmann, WJ,  et al. 1998Survival and recurrence after liver transplantation versus resection for hepatocellular carcinoma: a retrospective analysisAnn. Surg.227424432CrossRefPubMed
8.
Zurück zum Zitat Kosuge, T, Makuuchi, M, Takayama, T, et al. 1993Long-term results after resection of hepatocellular carcinoma: experience of 480 casesHepatogastroenterology40328332PubMed Kosuge, T, Makuuchi, M, Takayama, T,  et al. 1993Long-term results after resection of hepatocellular carcinoma: experience of 480 casesHepatogastroenterology40328332PubMed
9.
Zurück zum Zitat Adachi, E, Maeda, T, Kajiyama, K, et al. 1996Factors correlated with portal venous invasion by hepatocellular carcinoma: univariate and multivariate analyses of 232 resected cases without preoperative treatmentsCancer7720222031CrossRefPubMed Adachi, E, Maeda, T, Kajiyama, K,  et al. 1996Factors correlated with portal venous invasion by hepatocellular carcinoma: univariate and multivariate analyses of 232 resected cases without preoperative treatmentsCancer7720222031CrossRefPubMed
10.
Zurück zum Zitat Nagasue, N, Uchida, M, Makino, Y, et al. 1993Incidence and factors associated with intrahepatic recurrence following resection of hepatocellular carcinomaGastroenterology105488494PubMed Nagasue, N, Uchida, M, Makino, Y,  et al. 1993Incidence and factors associated with intrahepatic recurrence following resection of hepatocellular carcinomaGastroenterology105488494PubMed
11.
Zurück zum Zitat Hanazaki, K, Kajikawa, S, Shimozawa, N, et al. 2001Hepatic resection for hepatocellular carcinoma in the elderlyJ. Am. Coll. Surg.1923846CrossRefPubMed Hanazaki, K, Kajikawa, S, Shimozawa, N,  et al. 2001Hepatic resection for hepatocellular carcinoma in the elderlyJ. Am. Coll. Surg.1923846CrossRefPubMed
12.
Zurück zum Zitat Ko, S, Nakajima, Y, Kanehiro, H, et al. 1996Significant influence of accompanying chronic hepatitis status on recurrence of hepatocellular carcinoma after hepatectomy. Results of multivariate analysisAnn. Surg.224591595CrossRefPubMed Ko, S, Nakajima, Y, Kanehiro, H,  et al. 1996Significant influence of accompanying chronic hepatitis status on recurrence of hepatocellular carcinoma after hepatectomy. Results of multivariate analysisAnn. Surg.224591595CrossRefPubMed
13.
Zurück zum Zitat Tung-Ping Poon, R, Fan, ST, Oi-Lin Ng, I, et al. 2000Significance of resection margin in hepatectomy for hepatocellular carcinoma—A critical reappraisalAnn. Surg.231544551CrossRefPubMed Tung-Ping Poon, R, Fan, ST, Oi-Lin Ng, I,  et al. 2000Significance of resection margin in hepatectomy for hepatocellular carcinoma—A critical reappraisalAnn. Surg.231544551CrossRefPubMed
14.
Zurück zum Zitat Tsai, TJ, Chau, GY, Lui, WY, et al. 1997Clinical significance of microscopic tumor venous invasion in patients with resectable hepatocellular carcinomaSurgery7915011508 Tsai, TJ, Chau, GY, Lui, WY,  et al. 1997Clinical significance of microscopic tumor venous invasion in patients with resectable hepatocellular carcinomaSurgery7915011508
15.
Zurück zum Zitat Imamura, H, Matsuyama, Y, Tanaka, E, et al. 2003Risk factors contributing to early and late phase intrahepatic recurrence of hepatocellular carcinoma after hepatectomyJ. Hepatol.38200207CrossRefPubMed Imamura, H, Matsuyama, Y, Tanaka, E,  et al. 2003Risk factors contributing to early and late phase intrahepatic recurrence of hepatocellular carcinoma after hepatectomyJ. Hepatol.38200207CrossRefPubMed
16.
Zurück zum Zitat Poon, RT, Fan, ST, Ng, IO, et al. 2000Different risk factors and prognosis for early and late intrahepatic recurrence after resection of hepatocellular carcinomaCancer89500507CrossRefPubMed Poon, RT, Fan, ST, Ng, IO,  et al. 2000Different risk factors and prognosis for early and late intrahepatic recurrence after resection of hepatocellular carcinomaCancer89500507CrossRefPubMed
17.
Zurück zum Zitat Kawamura, M, Fujimoto, S, Hisanaga, S, et al. 1998Incidence, outcome, and risk factors of cerebrovascular events in patients undergoing maintenance hemodialysisAm. J. Kidney Dis.31991996PubMed Kawamura, M, Fujimoto, S, Hisanaga, S,  et al. 1998Incidence, outcome, and risk factors of cerebrovascular events in patients undergoing maintenance hemodialysisAm. J. Kidney Dis.31991996PubMed
18.
Zurück zum Zitat Rabb, H, Wang, Z, Nemoto, T, et al. 2003Acute renal failure leads to dysregulation of lung salt and water channelsKidney Int.63600606CrossRefPubMed Rabb, H, Wang, Z, Nemoto, T,  et al. 2003Acute renal failure leads to dysregulation of lung salt and water channelsKidney Int.63600606CrossRefPubMed
19.
Zurück zum Zitat Suwaidi, JAI, Reddan, DN, Williams, K, et al. 2002Prognostic implications of abnormalities in renal function in patients with acute coronary syndromesCirculation106974980CrossRefPubMed Suwaidi, JAI, Reddan, DN, Williams, K,  et al. 2002Prognostic implications of abnormalities in renal function in patients with acute coronary syndromesCirculation106974980CrossRefPubMed
20.
Zurück zum Zitat Dixon, SR, O’Neill, WW, Sadeghi, HM, et al. 2003Usefulness of creatinine clearance in predicting early and late death after primary angioplasty for acute myocardial infarctionAm.J.Cardiol.9114541457CrossRefPubMed Dixon, SR, O’Neill, WW, Sadeghi, HM,  et al. 2003Usefulness of creatinine clearance in predicting early and late death after primary angioplasty for acute myocardial infarctionAm.J.Cardiol.9114541457CrossRefPubMed
21.
Zurück zum Zitat Hayashi, H, Ohtake, Y, Kashima, T, et al. 1999Hepatocellular carcinoma among hemodialysis patients infected with hepatitis C virus—early evolution and rapid prognosisClin. Nephrol.51321323PubMed Hayashi, H, Ohtake, Y, Kashima, T,  et al. 1999Hepatocellular carcinoma among hemodialysis patients infected with hepatitis C virus—early evolution and rapid prognosisClin. Nephrol.51321323PubMed
22.
Zurück zum Zitat Mailloux, LU, Bellucci, AG, Wilkes, BM, et al. 1991Mortality in dialysis patients: analysis of the causes of deathAm. J. Kidney Dis.18326335PubMed Mailloux, LU, Bellucci, AG, Wilkes, BM,  et al. 1991Mortality in dialysis patients: analysis of the causes of deathAm. J. Kidney Dis.18326335PubMed
23.
Zurück zum Zitat Bosch, J, Garcia-Pagan, JC 2000Complications of cirrhosis I. Portal hypertensionJ Hepatol32141155CrossRefPubMed Bosch, J, Garcia-Pagan, JC 2000Complications of cirrhosis I. Portal hypertensionJ Hepatol32141155CrossRefPubMed
24.
Zurück zum Zitat Groszmann, RJ 1994Hyperdynamic circulation of liver disease 40 years later: pathophysiology and clinical consequencesHepatology2013591363CrossRefPubMed Groszmann, RJ 1994Hyperdynamic circulation of liver disease 40 years later: pathophysiology and clinical consequencesHepatology2013591363CrossRefPubMed
25.
Zurück zum Zitat Arroyo, V, Jimenez, W 2000Complications of cirrhosis II. Renal and circulatory dysfunction. Lights and shadows in an important clinical problemJ. Hepatol.32157170CrossRefPubMed Arroyo, V, Jimenez, W 2000Complications of cirrhosis II. Renal and circulatory dysfunction. Lights and shadows in an important clinical problemJ. Hepatol.32157170CrossRefPubMed
26.
Zurück zum Zitat Epstein, M 1997Hepatorenal syndrome: emerging perspectivesSemin. Nephrol.17563575PubMed Epstein, M 1997Hepatorenal syndrome: emerging perspectivesSemin. Nephrol.17563575PubMed
27.
Zurück zum Zitat Cheng, SB, Wu, CC, Shu, KH, et al. 2001Liver resection for hepatocellular carcinoma in patients with end-stage renal failureJ. Surg. Oncol.78241247CrossRefPubMed Cheng, SB, Wu, CC, Shu, KH,  et al. 2001Liver resection for hepatocellular carcinoma in patients with end-stage renal failureJ. Surg. Oncol.78241247CrossRefPubMed
28.
Zurück zum Zitat Black, RM, Howard, J, Pang-yen, A, et al. 1996Rose & Black’s Clinical Problems in NephrologyHippincott Williams and WilkinsPhiladelphia186187 Black, RM, Howard, J, Pang-yen, A,  et al. 1996Rose & Black’s Clinical Problems in NephrologyHippincott Williams and WilkinsPhiladelphia186187
29.
Zurück zum Zitat Ikeda, Y, Shimada, M, Hasegawa, H, et al. 1998Prognosis of hepatocellular carcinoma with diabetes mellitus after hepatic resectionHepatology2715671571CrossRefPubMed Ikeda, Y, Shimada, M, Hasegawa, H,  et al. 1998Prognosis of hepatocellular carcinoma with diabetes mellitus after hepatic resectionHepatology2715671571CrossRefPubMed
30.
Zurück zum Zitat Shimada, M, Matsumata, T, Akazawa, K, et al. 1994Estimation of risk of major complications after hepatic resectionAm J Surg167399403CrossRefPubMed Shimada, M, Matsumata, T, Akazawa, K,  et al. 1994Estimation of risk of major complications after hepatic resectionAm J Surg167399403CrossRefPubMed
31.
Zurück zum Zitat Penn, I 1970Malignant tumors in organ transplant recipientsSpringer-VerlagNew York Penn, I 1970Malignant tumors in organ transplant recipientsSpringer-VerlagNew York
32.
Zurück zum Zitat Matas, AJ, Simmons, RL, Kjellstrand, CM, et al. 1975Increased incidence of malignancy during chronic renal failureLancet19883886CrossRef Matas, AJ, Simmons, RL, Kjellstrand, CM,  et al. 1975Increased incidence of malignancy during chronic renal failureLancet19883886CrossRef
33.
Zurück zum Zitat Curtis, JR 1982Cancer and patients with end-stage renal failureBr. Med. J.2846970 Curtis, JR 1982Cancer and patients with end-stage renal failureBr. Med. J.2846970
34.
Zurück zum Zitat Miach, PJ, Dawborn, JK, Xipell, J 1976Neoplasia in patients with chronic renal failure on long-term dialysisClin. Nephrol.5101104PubMed Miach, PJ, Dawborn, JK, Xipell, J 1976Neoplasia in patients with chronic renal failure on long-term dialysisClin. Nephrol.5101104PubMed
35.
Zurück zum Zitat Cengiz, K 2002Increased incidence of neoplasia in chronic renal failure (20-year experience)Int. Urol. Nephrol.33121126CrossRefPubMed Cengiz, K 2002Increased incidence of neoplasia in chronic renal failure (20-year experience)Int. Urol. Nephrol.33121126CrossRefPubMed
36.
Zurück zum Zitat Vamvakas, S, Bahner, U, Heidland, A 1998Cancer in end-stage renal disease: potential factors involvedAm. J. Nephrol.188995CrossRefPubMed Vamvakas, S, Bahner, U, Heidland, A 1998Cancer in end-stage renal disease: potential factors involvedAm. J. Nephrol.188995CrossRefPubMed
37.
Zurück zum Zitat Lencioni, RA, Allgaier, HP, Cioni, D, et al. 2003Small hepatocellular carcinoma in cirrhosis: randomized comparison of radio-frequency thermal ablation versus percutaneous ethanol injectionRadiology228235240PubMed Lencioni, RA, Allgaier, HP, Cioni, D,  et al. 2003Small hepatocellular carcinoma in cirrhosis: randomized comparison of radio-frequency thermal ablation versus percutaneous ethanol injectionRadiology228235240PubMed
38.
Zurück zum Zitat Morimoto, M, Sugimori, K, Shirato, K, et al. 2002Treatment of hepatocellular carcinoma with radiofrequency ablation: radiologic-histologic correlation during follow-up periodsHepatology3514671475CrossRefPubMed Morimoto, M, Sugimori, K, Shirato, K,  et al. 2002Treatment of hepatocellular carcinoma with radiofrequency ablation: radiologic-histologic correlation during follow-up periodsHepatology3514671475CrossRefPubMed
39.
Zurück zum Zitat Teratani, T, Ishikawa, T, Shiratori, Y, et al. 2002Hepatocellular carcinoma in elderly patients: benefical therapeutic efficacy using percutaneous ethanol injection therapyCancer95816823CrossRefPubMed Teratani, T, Ishikawa, T, Shiratori, Y,  et al. 2002Hepatocellular carcinoma in elderly patients: benefical therapeutic efficacy using percutaneous ethanol injection therapyCancer95816823CrossRefPubMed
40.
Zurück zum Zitat Koike, Y, Shiratori, Y, Sato, S, et al. 2000Risk factors for recurring hepatocellular carcinoma differ according to infected hepatitis virus-an analysis of 236 consecutive patients with a single lesionHepatology3212161223CrossRefPubMed Koike, Y, Shiratori, Y, Sato, S,  et al. 2000Risk factors for recurring hepatocellular carcinoma differ according to infected hepatitis virus-an analysis of 236 consecutive patients with a single lesionHepatology3212161223CrossRefPubMed
Metadaten
Titel
Prognosis of Hepatocellular Carcinoma after Hepatectomy in Patients with Renal Dysfunction
verfasst von
Masaki Kaibori, M.D.
Yoichi Matsui, M.D.
A-Hon Kwon, M.D.
Toshiko Tokoro, M.D.
Yasuo Kamiyama, M.D.
Publikationsdatum
01.03.2005
Erschienen in
World Journal of Surgery / Ausgabe 3/2005
Print ISSN: 0364-2313
Elektronische ISSN: 1432-2323
DOI
https://doi.org/10.1007/s00268-004-7515-0

Weitere Artikel der Ausgabe 3/2005

World Journal of Surgery 3/2005 Zur Ausgabe

Wie erfolgreich ist eine Re-Ablation nach Rezidiv?

23.04.2024 Ablationstherapie Nachrichten

Nach der Katheterablation von Vorhofflimmern kommt es bei etwa einem Drittel der Patienten zu Rezidiven, meist binnen eines Jahres. Wie sich spätere Rückfälle auf die Erfolgschancen einer erneuten Ablation auswirken, haben Schweizer Kardiologen erforscht.

Hinter dieser Appendizitis steckte ein Erreger

23.04.2024 Appendizitis Nachrichten

Schmerzen im Unterbauch, aber sonst nicht viel, was auf eine Appendizitis hindeutete: Ein junger Mann hatte Glück, dass trotzdem eine Laparoskopie mit Appendektomie durchgeführt und der Wurmfortsatz histologisch untersucht wurde.

Mehr Schaden als Nutzen durch präoperatives Aussetzen von GLP-1-Agonisten?

23.04.2024 Operationsvorbereitung Nachrichten

Derzeit wird empfohlen, eine Therapie mit GLP-1-Rezeptoragonisten präoperativ zu unterbrechen. Eine neue Studie nährt jedoch Zweifel an der Notwendigkeit der Maßnahme.

Ureterstriktur: Innovative OP-Technik bewährt sich

19.04.2024 EAU 2024 Kongressbericht

Die Ureterstriktur ist eine relativ seltene Komplikation, trotzdem bedarf sie einer differenzierten Versorgung. In komplexen Fällen wird dies durch die roboterassistierte OP-Technik gewährleistet. Erste Resultate ermutigen.

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

Karpaltunnelsyndrom BDC Leitlinien Webinare
CME: 2 Punkte

Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.

Prof. Dr. med. Gregor Antoniadis
Berufsverband der Deutschen Chirurgie e.V.

S2e-Leitlinie „Distale Radiusfraktur“

Radiusfraktur BDC Leitlinien Webinare
CME: 2 Punkte

Das Webinar beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?

PD Dr. med. Oliver Pieske
Dr. med. Benjamin Meyknecht
Berufsverband der Deutschen Chirurgie e.V.

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“

Appendizitis BDC Leitlinien Webinare
CME: 2 Punkte

Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.

Dr. med. Mihailo Andric
Berufsverband der Deutschen Chirurgie e.V.